New inhaled treatment tested for deadly lung pressure complication
NCT ID NCT07285655
Summary
This study is testing whether an inhaled medication called L606 can help people with high blood pressure in their lungs caused by lung scarring (interstitial lung disease). Researchers will measure if participants can walk farther and if the treatment delays worsening of their condition. About 344 participants will be randomly assigned to receive either L606 or a placebo, with everyone monitored closely for safety.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for PULMONARY HYPERTENSION DUE TO LUNG DISEASE (DISORDER) are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Conditions
Explore the condition pages connected to this study.